Showing results (61-70 of 296) with videos related to
Sort By:
Pageof 30
The American Journal of Geriatric Pharmacotherapy|December 11, 2012
Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sexConnie Marras, Nathan Herrmann, Geoffrey M Anderson, et al.Neurology. Clinical Practice|September 3, 2021
Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as MudLana M Chahine, Briana Edison, Margaret Daeschler, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 29, 2023
Disease Progression and Sphingolipids and Neurofilament Light Chain in Early Idiopathic Parkinson's DiseaseBlas Couto, Mario Sousa, Paulina Gonzalez-Latapi, et al.Parkinsonism & Related Disorders|July 30, 2018
Reproducibility of data-driven Parkinson's disease subtypes for clinical researchTiago A Mestre, Shirley Eberly, Caroline Tanner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always betterTiago A Mestre, Alberto J Espay, Connie Marras, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 30, 2025
Differences in Parkinson's Disease Populations: Teaching Hospitals Versus Other Settings and Implications for Clinical TrialsPriti Gros, Connie Marras, Xuesong Wang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2007
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trialConnie Marras, Michael P McDermott, Paula A Rochon, et al.World Journal of Urology|February 17, 2017
Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancerJames W S Young, Rinku Sutradhar, Jagadish Rangrej, et al.Journal of Patient-Centered Research and Reviews|July 29, 2021
The Experience of OFF Periods in Parkinson's Disease: Descriptions, Triggers, and Alleviating FactorsSneha Mantri, Madeline Lepore, Briana Edison, et al.Pharmacoepidemiology and Drug Safety|February 26, 2011
Confounders and intermediaries in case-control study designs: a strategy for distinguishing between the two when measured using the same variableAndrea Gruneir, Connie Marras, Hadas Fischer, et al.Pageof 30